We_PRP also_RB showed_VBD that_IN this_DT silencer_NN has_VBZ stronger_JJR inhibitory_JJ activity_NN in_IN HeLa_NN cells_NNS ,_, as_IN compared_VBN to_TO K562_NN human_JJ erythroleukemia_NN cells_NNS ._.
Dimerization_NN among_IN transcription_NN factors_NNS has_VBZ become_VBN a_DT recurrent_JJ theme_NN in_IN the_DT regulation_NN of_IN eukaryotic_JJ gene_NN expression_NN ._.
The_DT induction_NN of_IN the_DT AP-1_NN transcription_NN factor_NN has_VBZ been_VBN ascribed_VBN to_TO the_DT early_JJ events_NNS leading_VBG to_TO T_NN cell_NN differentiation_NN and_CC activation_NN ._.
Structurally_RB related_JJ divalent_JJ cations_NNS like_IN cobalt_NN ,_, nickel_NN ,_, and_CC mercury_NN also_RB partially_RB increase_VBP monokine_NN secretion_NN but_CC to_TO a_DT much_RB lower_JJR and_CC thus_RB insignificant_JJ extent_NN ._.
The_DT lymphoid-specific_JJ transcription_NN complex_NN ,_, NF-AT_NN ,_, is_VBZ involved_VBN in_IN early_JJ gene_NN activation_NN in_IN T_NN cells_NNS and_CC is_VBZ assembled_VBN from_IN a_DT pre-existing_JJ ,_, T_NN cell_NN restricted_JJ cytoplasmic_JJ factor_NN and_CC an_DT inducible_JJ ubiquitous_JJ nuclear_JJ component_NN within_IN 30_CD min_NN after_IN activation_NN through_IN the_DT antigen_NN receptor_NN ._.
The_DT binding_NN activity_NN of_IN the_DT X1_NN box_NN DNA-binding_JJ protein_NN RFX_NN was_VBD examined_VBN and_CC found_VBN to_TO be_VB present_JJ in_IN wild-type_JJ B_NN cells_NNS and_CC the_DT mutant_JJ RJ2.2.5_NN but_CC was_VBD absent_JJ in_IN SJO_NN and_CC Jurkat_NN ._.
One_CD of_IN NF-kappa_NN B_NN unique_JJ properties_NNS is_VBZ posttranslational_JJ activation_NN via_IN release_NN of_IN an_DT inhibitory_JJ subunit_NN ,_, called_VBN inhibitor_NN of_IN NF-kappa_NN B_NN I_NN kappa_NN B_NN ,_, from_IN a_DT sequestered_JJ cytoplasmic_JJ form_NN ._.
Regulation_NN of_IN the_DT BZLF1_NN promoter_NN of_IN Epstein-Barr_JJ virus_NN by_IN second_JJ messengers_NNS in_IN anti-immunoglobulin-treated_JJ B_NN cells_NNS ._.
The_DT CD20_NN B1_NN gene_NN encodes_VBZ a_DT B_NN cell-specific_JJ protein_NN involved_VBN in_IN the_DT regulation_NN of_IN human_JJ B_NN cell_NN proliferation_NN and_CC differentiation_NN ._.
One_CD clone_NN DEG5_NN also_RB exerted_VBD a_DT high_JJ and_CC specific_JJ cytotoxicity_NN against_IN autologous_JJ cells_NNS pulsed_VBN with_IN ._.
To_TO delineate_VB the_DT effects_NNS of_IN these_DT motifs_NNS on_IN the_DT replicative_JJ capacity_NN of_IN HIV_NN and_CC to_TO explore_VB the_DT possibility_NN of_IN extending_VBG the_DT virus_NN host_NN range_NN ,_, known_VBN heterologous_JJ were_VBD inserted_VBN into_IN the_DT HIV-1_NN LTR_NN in_IN place_NN of_IN the_DT NF-kappa_NN B_NN and_CC Sp1_NN binding_NN sites_NNS ._.
A_DT PMA_NN responsive_JJ element_NN was_VBD localized_JJ to_TO a_DT region_NN between_IN -95_CD and_CC -36_CD bp_NN relative_JJ to_TO the_DT transcription_NN start_NN site_NN ._.
Nuclear_JJ factor-kappa_NN B_NN NF-kappa_NN B_NN is_VBZ a_DT transcription_NN factor_NN that_WDT binds_VBZ to_TO the_DT consensus_NN DNA_NN sequence_NN in_IN the_DT cis-acting_JJ elements_NNS of_IN various_JJ genes_NNS ._.
We_PRP have_VBP previously_RB shown_VBN that_IN after_IN a_DT mutation_NN of_IN Leu122_NN to_TO Arg_NN the_DT DNA_NN binding_NN basic_JJ domain_NN of_IN MyoD_NN confers_VBZ c-myc-like_JJ functional_JJ characteristics_NNS to_TO the_DT protein_NN ._.
Furthermore_RB ,_, we_PRP evaluated_VBD the_DT mineralocorticoid_NN receptor_NN MR_NN count_NN in_IN mononuclear_JJ leukocytes_NNS in_IN the_DT 2_CD groups_NNS ._.
Tissue_NN factor_NN expression_NN of_IN human_JJ monocytes_NNS is_VBZ suppressed_VBN by_IN lysophosphatidylcholine_NN ._.
By_IN assaying_VBG CAT_NN enzyme_NN activity_NN across_IN a_DT 24-h_JJ PRL_NN induction_NN time_NN course_NN ,_, we_PRP were_VBD able_JJ to_TO assign_VB G1_NN vs._CC S_NN phase_NN PRL_NN responses_NNS of_IN the_DT IRF-1_NN gene_NN to_TO different_JJ regions_NNS of_IN the_DT IRF-1_NN and_CC promoter_NN DNA_NN ._.
Multifactor_JJ cis-dominant_JJ negative_JJ regulation_NN of_IN IL-2_NN gene_NN expression_NN in_IN anergized_VBN T_NN cells_NNS ._.
Rather_RB ,_, TNF_NN and_CC PMA_NN can_MD exert_VB effect_NN only_RB if_IN cells_NNS are_VBP in_IN an_DT appropriate_JJ redox_NN status_NN ,_, because_IN prior_JJ modification_NN toward_IN reduction_NN with_IN BHA_NN treatment_NN prevents_VBZ this_DT activation_NN ._.
An_DT IL-2_NN response_NN element_NN in_IN the_DT human_JJ IL-2_NN receptor_NN alpha_NN chain_NN promoter_NN is_VBZ a_DT composite_JJ element_NN that_WDT binds_VBZ Stat5_NN ,_, Elf-1_NN ,_, HMG-I-LRB-Y-RRB-_NN and_CC a_DT GATA_NN family_NN protein_NN ._.
These_DT results_NNS indicate_VBP that_IN ,_, among_IN HIV1_NN gene_NN products_NNS ,_, the_DT Tat_NN protein_NN appears_VBZ to_TO trigger_VB monocytic_JJ differentiation_NN ,_, and_CC suggests_VBZ that_IN this_DT viral_JJ protein_NN directs_VBZ progenitors_NNS of_IN the_DT lineage_NN towards_IN a_DT differentiation_NN stage_NN in_IN which_WDT production_NN of_IN viral_JJ antigens_NNS and_CC virions_NNS might_MD be_VB more_RBR efficient_JJ ._.
Two_CD pp56-LRB-lck-RRB-_NN mutants_NNS lacking_VBG either_CC the_DT entire_JJ catalytic_JJ domain_NN or_CC the_DT entire_JJ NH2_NN regulatory_JJ domain_NN were_VBD generated_VBN ,_, and_CC abilities_NNS to_TO trigger_VB transactivation_NN of_IN the_DT TCR-regulated_JJ nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN region_NN of_IN the_DT IL-2_NN promoter_NN were_VBD compared_VBN ._.
Induction_NN of_IN fra-1_NN following_VBG engagement_NN of_IN CD40_NN did_VBD not_RB require_VB protein_NN synthesis_NN ,_, suggesting_VBG that_IN the_DT PKC-dependent_JJ linkage_NN between_IN CD40_NN and_CC fra-1_NN is_VBZ direct_JJ ._.
However_RB ,_, hypercalcemia_NN is_VBZ a_DT side_JJ effect_NN ,_, which_WDT is_VBZ caused_VBN by_IN VD_NN classical_JJ action_NN ,_, the_DT regulation_NN of_IN calcium_NN homeostasis_NN ._.
Expression_NN of_IN DR3_NN appears_VBZ to_TO be_VB restricted_JJ to_TO tissues_NNS enriched_VBN in_IN lymphocytes_NNS ._.
Induction_NN of_IN the_DT POU_NN domain_NN transcription_NN factor_NN Oct-2_NN during_IN T-cell_NN activation_NN by_IN cognate_JJ antigen_NN ._.
However_RB ,_, this_DT factor_NN appeared_VBD when_WRB these_DT CML_NN patients_NNS achieved_VBD complete_JJ haematological_JJ remission_NN CHR_NN through_IN alpha-interferon_NN therapy_NN ._.
We_PRP have_VBP used_VBN a_DT 32P-labeled_JJ oligonucleotide_NN derived_VBN from_IN human_JJ immunodeficiency_NN virus_NN HIV-1_NN long_JJ terminal_JJ repeat_NN ,_, which_WDT contains_VBZ a_DT tandem_JJ repeat_NN of_IN the_DT NF_NN kappa_NN B_NN binding_NN sequence_NN ,_, as_IN a_DT probe_NN in_IN a_DT gel_NN retardation_NN assay_NN to_TO study_VB this_DT transcription_NN factor_NN ._.
We_PRP have_VBP found_VBN that_IN purified_VBN human_JJ peripheral-blood_JJ granulocytes_NNS express_VBP constitutively_RB significant_JJ levels_NNS of_IN proto-oncogenes_NNS c-jun_NN ,_, jun_NN B_NN and_CC jun_NN D_NN mRNA_NN ._.
We_PRP showed_VBD that_IN both_CC IL-10_NN and_CC IL-4_NN inhibit_VBP LPS-induced_JJ IL-6_NN mRNA_NN and_CC protein_NN expression_NN by_IN inhibiting_VBG the_DT transcription_NN rate_NN of_IN the_DT IL-6_NN gene_NN ._.
In_IN this_DT report_NN ,_, we_PRP show_VBP that_IN upon_IN the_DT stimulation_NN of_IN both_DT pathways_NNS T_NN lymphocytes_NNS became_VBD refractory_JJ to_TO activation_NN via_IN the_DT cell_NN receptor_NN TcR_NN complex_NN ._.
G0S24_NN has_VBZ potential_JJ sites_NNS for_IN transcription_NN factors_NNS in_IN the_DT flank_NN and_CC intron_NN ;_: these_DT include_VBP a_DT serum_NN response_NN element_NN ._.
Although_IN ,_, the_DT level_NN of_IN MNDA_NN mRNA_NN in_IN primary_JJ monocytes_NNS is_VBZ very_RB low_JJ it_PRP was_VBD up-regulated_VBN at_IN 6_CD h_NN following_VBG the_DT addition_NN of_IN interferon_NN alpha_NN ._.
Neither_CC Bt2cAMP_NN nor_CC PMA_NN individually_RB mediated_VBD these_DT sustained_JJ effects_NNS ,_, which_WDT therefore_RB appear_VBP as_IN a_DT consequence_NN of_IN the_DT interplay_NN between_IN both_DT metabolic_JJ stimuli_NNS ._.
The_DT previously_RB defined_VBN minimal_JJ enhancer_NN containing_VBG the_DT muA_NN ,_, muE3_NN ,_, and_CC muB_NN sites_NNS is_VBZ transactivated_VBN by_IN a_DT combination_NN of_IN the_DT ETS-domain_NN proteins_NNS PU.1_NN and_CC Ets-1_NN in_IN nonlymphoid_JJ cells_NNS ._.
These_DT results_NNS provide_VBP the_DT first_JJ direct_JJ evidence_NN for_IN the_DT requirement_NN of_IN GATA-1_NN and_CC NF-E2_NN in_IN BA-induced_JJ differentiation_NN process_NN ._.
The_DT cytokine_NN TNF_NN mediates_VBZ many_JJ of_IN the_DT pathologic_JJ signs_NNS of_IN cachexia_NN ,_, inflammation_NN ,_, and_CC sepsis_NN ._.
analyses_NNS show_VBP that_IN several_JJ Oct2_NN isoforms_NNS can_MD stimulate_VB from_IN a_DT remote_JJ position_NN but_CC that_IN this_DT stimulation_NN is_VBZ restricted_JJ to_TO B_NN cells_NNS ._.
Two_CD subclones_NNS were_VBD found_VBN to_TO have_VB an_DT abnormal_JJ response_NN to_TO the_DT protein_NN kinase_NN C_NN PKC_NN activator_NN PMA_NN ._.
Antiserum_NN specific_JJ for_IN NF-kappa_NN B_NN binding_NN proteins_NNS ,_, but_CC not_RB c-rel-specific_JJ antiserum_NN ,_, disrupted_VBD heterodimer_NN complex_NN formation_NN ._.
Similarly_RB ,_, covalent_JJ modification_NN of_IN free_JJ sulfhydryl_NN groups_NNS with_IN diamide_NN reversible_JJ or_CC N-ethylmaleimide_NN irreversible_JJ results_VBZ in_IN a_DT complete_JJ loss_NN of_IN DNA_NN binding_NN activity_NN ._.
Lipopolysaccharide_NN induces_VBZ phosphorylation_NN of_IN MAD3_NN and_CC activation_NN of_IN c-Rel_NN and_CC related_JJ NF-kappa_NN B_NN proteins_NNS in_IN human_JJ monocytic_JJ THP-1_NN cells_NNS ._.
Sequencing_NN of_IN the_DT GR_NN cDNA_NN and_CC gene_NN including_VBG the_DT 2.3-kb_JJ coding_NN region_NN ,_, the_DT junctions_NNS ,_, the_DT known_JJ region_NN ,_, and_CC approximately_RB 300_CD bp_NN of_IN the_DT revealed_VBD no_DT alterations_NNS ._.
Western_NN blot_NN with_IN an_DT N-terminal_JJ antibody_NN showed_VBD normal_JJ levels_NNS of_IN immunoreactive_JJ GR_NN ,_, but_CC quantitative_JJ analysis_NN with_IN isoform-specific_JJ C-terminal_JJ antibodies_NNS revealed_VBD a_DT markedly_RB reduced_VBN GRalpha_NN expression_NN ,_, and_CC high_JJ GRbeta_NN expression_NN ._.
In_IN contrast_NN to_TO wild-type_JJ B_NN cells_NNS ,_, neither_DT of_IN the_DT class_NN II_CD mutant_JJ cell_NN lines_NNS could_MD use_VB the_DT X_NN box_NN region_NN to_TO direct_VB the_DT expression_NN of_IN a_DT transiently_RB transfected_VBN reporter_NN gene_NN ,_, indicating_VBG that_IN the_DT X_NN box-dependent_JJ transcriptional_JJ pathway_NN is_VBZ defective_JJ in_IN these_DT cells_NNS ._.
Previously_RB ,_, transcription_NN of_IN the_DT c-fos_NN gene_NN has_VBZ been_VBN reported_VBN to_TO be_VB transactivated_VBN by_IN the_DT viral_JJ transcription_NN factor_NN ,_, Tax1_NN ._.
Correlations_NNS were_VBD found_VBN between_IN plasma_NN IFN_NN alpha_NN and_CC receptor_NN Kd_NN on_IN monocytes_NNS of_IN AIDS-GR_NN r_NN 0.77_CD and_CC between_IN IFN_NN alpha_NN and_CC plasma_NN cortisol_NN in_IN the_DT same_JJ group_NN r_NN 0.74_CD ._.
The_DT long_JJ terminal_JJ repeat_NN LTR_NN of_IN the_DT type_NN 1_CD human_JJ immunodeficiency_NN virus_NN HIV-1_NN and_CC the_DT regulatory_JJ region_NN of_IN the_DT gene_NN encoding_VBG the_DT interleukin_NN 2_CD receptor_NN alpha_NN subunit_NN IL-2R_NN alpha_NN share_NN functional_JJ kappa_NN B_NN enhancer_NN elements_NNS involved_VBN in_IN the_DT regulation_NN of_IN these_DT inducible_JJ transcription_NN units_NNS during_IN T-cell_NN activation_NN ._.
Various_JJ cellular_JJ stimuli_NNS relieve_VBP this_DT inhibition_NN by_IN mechanisms_NNS largely_RB unknown_JJ ,_, leading_VBG to_TO NF-kappa_NN B_NN nuclear_JJ localization_NN and_CC transactivation_NN of_IN target_NN genes_NNS ._.
This_DT protein_NN also_RB binds_VBZ to_TO the_DT immunoglobulin_NN heavy-chain_NN enhancer_NN mu_NN E1_NN site_NN ._.
